BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 7995950)

  • 1. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
    Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
    J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.
    Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoattractant-induced release of elastase by tumor necrosis factor-primed human neutrophils: auto-regulation by endogenous adenosine.
    Ottonello L; Amelotti M; Barbera P; Dapino P; Mancini M; Tortolina G; Dallegri F
    Inflamm Res; 1999 Dec; 48(12):637-42. PubMed ID: 10669115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
    Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE
    Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.
    Foissier L; Lonchampt M; Cogé F; Canet E
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1484-90. PubMed ID: 8819536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1 attenuates homotypic human neutrophil aggregation through inhibition of phosphodiesterase activity.
    Hwang TL; Zhuo SK; Pan YL
    Eur J Pharmacol; 2008 Jan; 579(1-3):395-402. PubMed ID: 18001706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes.
    Thibault N; Burelout C; Harbour D; Borgeat P; Naccache PH; Bourgoin SG
    J Leukoc Biol; 2002 Feb; 71(2):367-77. PubMed ID: 11818459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine inhibits actin dynamics in human neutrophils: evidence for the involvement of cAMP.
    Zalavary S; Bengtsson T
    Eur J Cell Biol; 1998 Feb; 75(2):128-39. PubMed ID: 9548370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell surface glycoprotein Mac-1 (CD11b/CD18) mediates neutrophil adhesion and modulates degranulation independently of its quantitative cell surface expression.
    Schleiffenbaum B; Moser R; Patarroyo M; Fehr J
    J Immunol; 1989 May; 142(10):3537-45. PubMed ID: 2565926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
    Lagente V; Hichami A; Boichot E; Martins MA; Silva PM
    Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
    Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
    J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase mediates chemoattractant-stimulated, CD11b/CD18-dependent cell-cell adhesion of human neutrophils: evidence for an ERK-independent pathway.
    Capodici C; Hanft S; Feoktistov M; Pillinger MH
    J Immunol; 1998 Feb; 160(4):1901-9. PubMed ID: 9469452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils.
    Shappell SB; Toman C; Anderson DC; Taylor AA; Entman ML; Smith CW
    J Immunol; 1990 Apr; 144(7):2702-11. PubMed ID: 2181020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase inhibitor.
    Patrizio M; Costa T; Levi G
    Glia; 1995 Jun; 14(2):94-100. PubMed ID: 7558245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ; Maurice DH
    Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst.
    Nielson CP; Vestal RE; Sturm RJ; Heaslip R
    J Allergy Clin Immunol; 1990 Nov; 86(5):801-8. PubMed ID: 1977788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.